Clinical trials recruiting for Hormone Receptor Positive Tumor
10
Recruiting trials
33
US states with sites
26
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Apatinib | 2 |
| Dalpiciclib | 2 |
| Famitinib | 2 |
| Fluzoparib | 2 |
| Fulvestrant | 2 |
| Goserelin | 2 |
| SHR-A1811 | 2 |
| SHR-A1921 | 2 |
| 9MW2821 | 1 |
| ABT-888 | 1 |
| AKT inhibitor | 1 |
| AMG 386 and Trastuzumab | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Michigan | 5 |
| Texas | 4 |
| California | 3 |
| Florida | 3 |
| Georgia | 3 |
| New York | 3 |
| Virginia | 3 |
| Arizona | 2 |
| Colorado | 2 |
| Connecticut | 2 |
| District of Columbia | 2 |
| Illinois | 2 |
Top cities
Houston, Texas 4Atlanta, Georgia 3Dallas, Texas 3Detroit, Michigan 3Los Angeles, California 3Boston, Massachusetts 2Buffalo, New York 2Chicago, Illinois 2Clarkston, Michigan 2Duarte, California 2
Self-screener
Recruiting trials
- A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer
- A Study of the TheraBionic P1 Device in Breast Cancer
- Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer
- Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
- Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
- Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- SNF Platform Study of HR+/ HER2-advanced Breast Cancer
- Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Related conditions
Trials recruiting for Hormone Receptor Positive Tumor often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239HER2- Negative Breast Cancer 57Advanced Breast Cancer 61PIK3CA Mutation 3Ovarian cancer 118Metastatic breast cancer 131Locally Advanced Breast Cancer 13HER2-positive breast cancer 75Early-stage Breast Cancer 27Breast Tumors 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Hormone Receptor Positive Tumor trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.